01456nam a2200205   4500001000700000010001500007100004100022101000800063200016800071210008300239215001800322330071800340606004101058606001601099606002201115606003301137606000901170606001101179710006001190384319  a9291680877  a20070531d1999       y0pory50      ba  aeng  aReport on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction, EMCDDA  aLuxembourgcOffice for Official Publications of the European Communitiesd1999  a114 p.d21 cm  aForeword. Abbreviations. Introduction. Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs. Council Decision of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties. Europol-EMCDDA progress report on 4-MTA in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Review of the pharmacotoxicological data on 4-MTA. Public health risks of 4-MTA: epidemiological evidence. Sociological and criminological evidence on the risks of 4-MTA. References. Participants in the risk-assessment process.  aPREVENÇÃO DA TOXICODEPENDÊNCIA  aRELATÓRIO  aDROGA SINTÉTICA  aCOOPERAÇÃO INTERNACIONAL  aOEDT  aEMCDDA  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION